Navigation Links
Æterna Zentaris Partner Keryx Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-0401) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer
Date:2/3/2010

Phase 3 X-PECT Trial (Xeloda(R) + Perifosine Evaluation in Colorectal cancer Treatment) to be led by Dr. Johanna Bendell, Director, GI Oncology Research, Sarah Cannon Research Institute

QUÉBEC CITY, Feb. 3 /PRNewswire-FirstCall/ - Æterna Zentaris Inc. (Nasdaq: AEZS; TSX: AEZ) (the "Company"), a late-stage drug development company specialized in oncology and endocrinology, today announced that its partner, Keryx Biopharmaceuticals ( KERX), has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial for its PI3K/Akt pathway inhibitor, perifosine (KRX-0401), in patients with refractory metastatic colorectal cancer. The SPA provides agreement that the Phase 3 study design adequately addresses objectives in support of a regulatory submission. Keryx is Æterna Zentaris' partner and licensee for perifosine in the United States, Canada and Mexico. Perifosine is also out-licensed to Handok in South Korea while Æterna Zentaris retains rights for the rest of the world.

About the Phase 3 Trial Design

The Phase 3 X-PECT (Xeloda(R) + Perifosine Evaluation in Colorectal cancer Treatment) trial will be a randomized (1:1), double-blind trial comparing the efficacy and safety of perifosine + capecitabine (capecitabine is a chemotherapy marketed by Roche as Xeloda(R)) vs. placebo + capecitabine in approximately 430 patients with refractory metastatic colorectal cancer. Patients must have failed available therapy including 5-fluorouracil (5-FU), oxaliplatin (Eloxatin(R)), irinotecan, bevacizumab (Avastin(R)) and, i
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Æterna Zentaris Partner Keryx Announces Positive Phase 2 Results for Perifosine as a Single Agent for the Treatment of Advanced Waldenstroms Macroglobulinemia
2. Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
3. Æterna Zentaris Receives NASDAQ Notification Related to Minimum Bid Price
4. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
5. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
6. AEterna Zentaris Announces Outcome of Managements Strategic Review
7. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
8. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
9. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
10. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
11. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... METTLER TOLEDO is pleased to launch ... CNS110 ScanTape™ . Replacing a traditional tape ... ease and accuracy for transport and logistics personnel. ... productivity—an important benefit for load planning and revenue ... , Usable at any point in goods-transfer ...
(Date:9/21/2014)... the University of Basel in Switzerland have succeeded ... charged molecule for the first time. These extremely ... of molecular properties and may also contribute to ... The results were published in the scientific journal ... of the interaction between matter and light, is ...
(Date:9/20/2014)... and PITTSFIELD, Massachusetts, USA (PRWEB) September 20, 2014 ... for the prestigious 2015 Prism Awards for Photonics ... product inventions from the multi-billion dollar optics and photonics ... society for optics and photonics , and Photonics ... as well as the versatility of photonics, said SPIE ...
(Date:9/19/2014)... (Nasdaq: ITMN ) today announced that it ... litigation in the Delaware Court of Chancery relating to ... August 22, 2014, among Roche Holdings, Inc., Klee Acquisition ... Memorandum of Understanding, the Company agreed to make certain ... the amendment to the Company,s Schedule 14D-9 to be ...
Breaking Biology Technology:ScanTape™ Handheld Dimensioner Increases Processing Volume 2Uncovering the forbidden side of molecules 2Entry deadline is 10 October for international photonics Prism Awards 2Entry deadline is 10 October for international photonics Prism Awards 3Entry deadline is 10 October for international photonics Prism Awards 4InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 2InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 3InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 4InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 5InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 6InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 7InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 8InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 9InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 10InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 11InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 12InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 13InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 14InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 15InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 16InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 17InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 18InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action 19
... MATK ) today announced its financial results ... 2008. Revenues for the fourth,quarter were $90.4 million, up ... 2007. Net income was $10.5 million, or $0.31 per ... with $18.3 million, or $0.55 per,diluted share, in last ...
... Myngle,( http://www.myngle.com ), the global language platform, ... at the Europe Unlimited,s European Venture Summit,(EVS) ( ... EVS is a showcase for the most ... energy entrepreneurs from all over Europe to meet,and ...
... Health-focused social networks,blogs, wikis and community ... but can be their biggest opportunities. A ... discuss increasing,importance of reputation monitoring and management ... User Generated Content and Enhancing its Impact,on ...
Cached Biology Technology:Martek Announces Fourth Quarter and FY 2008 Financial Results 2Martek Announces Fourth Quarter and FY 2008 Financial Results 3Martek Announces Fourth Quarter and FY 2008 Financial Results 4Martek Announces Fourth Quarter and FY 2008 Financial Results 5Martek Announces Fourth Quarter and FY 2008 Financial Results 6Martek Announces Fourth Quarter and FY 2008 Financial Results 7Martek Announces Fourth Quarter and FY 2008 Financial Results 8Martek Announces Fourth Quarter and FY 2008 Financial Results 9Martek Announces Fourth Quarter and FY 2008 Financial Results 10Martek Announces Fourth Quarter and FY 2008 Financial Results 11Myngle Best ICT Company at the European Ventures Summit 2Exclusive Conference on Managing Your Online Brand: Shaping the Noise from the Blogosphere 2
(Date:9/22/2014)... Ill. Antarctic fishes that manufacture their own ... Ocean also suffer an unfortunate side effect, researchers ... their bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences ... an undesirable consequence of the evolution of antifreeze ...
(Date:9/22/2014)... burn in Khabarovsk Krai, a territory occupying the coastline of ... plumes of smoke mark active fires. The smoke, which appears ... Sea of Okhotsk. Taiga and tundra are found ... central depression, and deciduous forests are the natural vegetation in ... in the summer, the 2014 wildfire season appears to be ...
(Date:9/22/2014)... may be at greater risk for stress-related diseases ... according to a new study by Brandeis University. ... trigger biological responses similar to the effects of ... is an important part of our body,s healing ... life-threatening diseases. , In a recently published ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3Obesity and stress pack a double hit for health 2
... in preserving and promoting a healthy cardiovascular system than ... researchers at the Medical College of Wisconsin in Milwaukee. ... the scientific journal Hypertension, was led by David D. ... medicine and physiology, and senior associate dean of research ...
... the red jungle fowl, but new research from Uppsala University ... more complicated than that. The researchers mapped ... found to their surprise that this genetic heredity derives from ... study is being published today in the Web edition of ...
... Option for Voluntary Use of Biometrics, WASHINGTON, ... Legal Workforce today applauded the introduction of,legislation viewed ... system and to helping prevent unauthorized,employment, a key ... The New Employee Verification Act (NEVA) introduced today ...
Cached Biology News:New study shows low-fat diets more likely to reduce risk of heart disease than low-carb diets 2Darwin was wrong about the wild origin of the chicken 2HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System 2HR Initiative Endorses Bill to Create an Effective, Mandatory Federal Employment Verification System 3
Human M-CSF...
Human IL-19 MAb (Clone 152112)...
Mouse Activin RIB/ALK-4 MAb (Clone 207304)...
... (1995) This book contains up ... current issues relating to the aetiology and ... have been made recently which greatly improve ... molecular neuropathology through clinical and diagnostic aspects, ...
Biology Products: